BioPharm News

Jan 16, 2018
By BioPharm International Editors
The acquisition strengthens Charles River Laboratories’ capabilities in the oncology and immunology therapeutic areas.
Jan 12, 2018
By BioPharm International Editors
An antibody-based Zika virus therapeutic that protected monkeys from infection might be safe enough for administration to pregnant women.
Jan 12, 2018
By BioPharm International Editors
A new target for the treatment of multiple myeloma using CAR-T technology was discovered by researchers at Osaka University.
Jan 12, 2018
By BioPharm International Editors
The acquisition, valued at EUR 520 million (US$631 million), would expand Takeda’s late-stage pipeline in gastroenterology and would extend an already existing collaboration between the two companies.
Jan 11, 2018
By BioPharm International Editors
The European Commission has approved AstraZeneca’s benralizumab, a monoclonal antibody for treating severe asthma.
Jan 11, 2018
By BioPharm International Editors
Athenex is moving forward with the construction of a new 320,000-square-foot pharmaceutical manufacturing facility in Dunkirk, NY, and has hired the German engineering firm, M+W, to design and construct the facility.
Jan 11, 2018
By BioPharm International Editors
The agency is requiring safety label changes to limit the use of prescription opioid cough and cold medicines in children younger than 18 years old.
Jan 11, 2018
By BioPharm International Editors
A Takeda and Denali collaboration includes three named programs for treating Alzheimer’s disease and other neurodegenerative diseases, using Denali’s antibody transport vehicle (ATV) technology to enhance blood-brain barrier penetration.
Jan 11, 2018
By BioPharm International Editors
The company will use funding from the Bill & Melinda Gates Foundation to develop a new production method for artemisinin, a therapeutic used to treat malaria.
Jan 11, 2018
By BioPharm International Editors
Sartorius Stedim Biotech will equip Abzena’s contract development and manufacturing facilities in Bristol, PA, and San Diego, CA, with single-use equipment and scale-up technologies.
native1_300x100
lorem ipsum